| 华召来,缪伟刚,朱永敬,等.2020年江苏省扬中市恶性肿瘤流行情况及2006—2020年变化趋势分析[J].中国肿瘤,2026,35(1):10-17. |
| 2020年江苏省扬中市恶性肿瘤流行情况及2006—2020年变化趋势分析 |
| Incidence and Mortality of Malignant Tumors in Yangzhong City， Jiangsu Province in 2020 and Trends from 2006 to 2020 |
| 投稿时间：2025-09-15 |
| DOI：10.11735/j.issn.1004-0242.2026.01.A002 |
|
 |
| 中文关键词: 恶性肿瘤 发病率 死亡率 趋势 江苏 |
| 英文关键词:malignant tumor incidence rate mortality rate trend Jiangsu |
| 基金项目: |
|
| 摘要点击次数: 0 |
| 全文下载次数: 0 |
| 中文摘要: |
| 摘 要：［目的］ 分析2020年江苏省扬中市主要恶性肿瘤的发病和死亡情况，评估2006—2020年的变化趋势。［方法］ 基于2006—2020年扬中市肿瘤登记处的户籍人口肿瘤登记数据（覆盖全市所有户籍居民）及扬中市公安局户籍管理系统的年度常住人口数据，按性别分层计算不同癌种的粗发病率/死亡率、中国人口标化发病率（age-standardized incidence rate by Chinese standard population，ASIRC）、中国人口标化死亡率（age-standardized mortality rate by Chinese standard population，ASMRC）、0~74岁累积发病（死亡）率，以及前10位恶性肿瘤发病（死亡）顺位。采用Joinpoint回归模型分析主要恶性肿瘤ASIRC和ASMRC的长期趋势，以年度变化百分比（annual percentage change，APC）和平均年度变化百分比（average annual percentage change，AAPC）表示。［结果］ 2020年扬中市新增恶性肿瘤病例1 264例，因恶性肿瘤死亡879例；全人群粗发病率为451.27/10万，ASIRC为191.34/10万，0~74岁累积发病率为21.24%；粗死亡率为313.82/10万，ASMRC为116.80/10万，0~74岁累积死亡率为11.26%。发病前5位恶性肿瘤依次为胃癌、食管癌、肺癌、结直肠癌、女性乳腺癌，死亡前5位依次为胃癌、食管癌、肺癌、结直肠癌、肝癌。2006—2020年，全人群所有恶性肿瘤ASIRC的AAPC为-2.48%（P<0.05），ASMRC的AAPC为-3.57%（P<0.05）。分癌种趋势显示：男女性食管癌、胃癌的ASIRC与ASMRC均显著下降（P均<0.05）；前列腺癌ASIRC与ASMRC均显著上升（AAPC分别为7.69%、6.09%，P均<0.05）；女性结直肠癌、肺癌ASIRC显著上升（AAPC分别为3.21%、6.51%，P均<0.05）。［结论］ 2006—2020年扬中市恶性肿瘤总体发病与死亡负担呈逐年下降趋势，但前列腺癌、女性结直肠癌及女性肺癌负担上升，需结合本地流行特征强化针对性防控，降低重点癌种疾病负担。 |
| 英文摘要: |
| Abstract：［Purpose］ To analyze the incidence and mortality of major malignant tumors in Yangzhong City， Jiangsu Province in 2020 and evaluate the changing trends from 2006 to 2020. ［Methods］ Based on the household registration population cancer registration data (covering all household registered residents in the city) from Yangzhong Cancer Registry and the annual permanent population data from the household registration management system of Yangzhong Public Security Bureau from 2006 to 2020， sex-stratified calculations were conducted for crude incidence/mortality rates of different cancer types， age-standardized incidence rate by Chinese standard population (ASIRC)， age-standardized mortality rate by Chinese standard population (ASMRC)， cumulative incidence (mortality) rates (0~74 years old)， and top 10 ranking of malignant tumor incidence (mortality). Joinpoint regression model was used to analyze the long-term trends of ASIRC and ASMRC of major malignant tumors， which were expressed by annual percentage change (APC) and average annual percentage change (AAPC). ［Results］ In Yangzhong City， 1 264 newly diagnosed cases and 879 deaths of malignant tumors were reported in 2020. The crude incidence rate of the total population was 451.27/105， ASIRC was 191.34/105， and cumulative incidence rate (0~74 years old) was 21.24%； the crude mortality rate was 313.82/105， ASMRC was 116.80/105， and cumulative mortality rate (0~74 years old) was 11.26%. The top 5 malignant tumors in terms of incidence were stomach cancer， esophageal cancer， lung cancer， colorectal cancer， and female breast cancer， while the top 5 malignant tumors in terms of mortality were stomach cancer， esophageal cancer， lung cancer， colorectal cancer， and liver cancer. From 2006 to 2020， the AAPC of ASIRC for all malignant tumors in the total population was -2.48% (P<0.05)， and the AAPC of ASMRC was -3.57% (P<0.05). Subtype analysis showed that ASIRC and ASMRC of esophageal cancer and gastric cancer decreased significantly in both male and female (all P<0.05)； ASIRC and ASMRC of prostate cancer increased significantly (AAPC：7.69%， 6.09%， respectively，both P<0.05)； ASIRC of colorectal cancer and lung cancer in female increased significantly (AAPC：3.21%， 6.51%， respectively， both P<0.05). ［Conclusion］ The overall burden of incidence and mortality of malignant tumors in Yangzhong City showed a year-by-year declining trend from 2006 to 2020， but the burden of colorectal cancer and lung cancer in females and the burden of prostate cancer increased. It is necessary to strengthen targeted prevention and control based on local epidemiological characteristics to reduce the disease burden of key cancer types. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |
|
|
|